A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphomaEva Hoster, Michael Unterhalt, Martin Dreyling et al.|Blood|2007Cited by 971
A New Prognostic Score for Survival of Patients With Chronic Myeloid Leukemia Treated With Interferon Alfa Writing Committee for the Collaborative CML Prognostic Factors Project GroupJoerg Hasford, Hassan Ansari, Markus Pfirrmann et al.|JNCI Journal of the National Cancer Institute|1998Cited by 820
Immunochemotherapy With Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Significantly Improves Response and Time to Treatment Failure, But Not Long-Term Outcome in Patients With Previously Untreated Mantle Cell Lymphoma: Results of a Prospective Randomized Trial of the German Low Grade Lymphoma Study Group (GLSG)Georg Lenz, Wolfgang Hiddemann, Martin Dreyling et al.|Journal of Clinical Oncology|2005Cited by 573
Predicting complete cytogenetic response and subsequent progression-free survival in 2060 patients with CML on imatinib treatment: the EUTOS scoreJoerg Hasford, Rüdiger Hehlmann, Gianantonio Rosti et al.|Blood|2011Cited by 497
Randomized comparison of interferon-alpha with busulfan and hydroxyurea in chronic myelogenous leukemia. The German CML Study Group [see comments]Rüdiger Hehlmann, B Heinze, H. Heimpel et al.|Blood|1994Cited by 458